Our team is working to improve the identification of patients with aggressive prostate cancer. To do this, we develop diagnostic and prognostic applications for tissue and optical markers. Our research projects are grouped into 2 main themes:

• Characterization of intraductal carcinoma of the prostate, an aggressive entity of prostate cancer.
• Integration of Raman spectroscopy in the clinical workflow.

Our research is funded by the Institut du cancer de Montréal, Prostate Cancer Canada, Fonds de recherche du Québec – Santé (FRQS), Cancer Research Society, MEDTEQ, Institute for data valorization (IVADO) and the Canadian Institutes of Health Research (CIHR).